Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz J Reike

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Urologic Clinics of North America|November 24, 2022
Biological Stratification of Invasive and Advanced Urothelial CarcinomaMoritz J Reike, Alberto Contreras-Sanz, Peter C Black
Urologic Oncology|December 31, 2023
A systematic review of nanocarriers for treatment of urologic cancersAmy J Y Wang, Cathy Yan, Moritz J Reike, et al.
Urologia Internationalis|December 30, 2025
Who needs a postoperative radiological anastomotic control following radical prostatectomy before catheter removal on postoperative day 3? - Analysis of risk factors predicting anastomotic leakageAnalena Handke, Martina Dellino, Joachim Noldus, et al.
Urologia Internationalis|December 16, 2024
Discrimination of T-Stage Using Tumor Weight and Size: A Potential Approach to Guide Perioperative Decision-Making in Patients with Bladder CancerKarl Tully, Henning Bahlburg, Moritz J Reike, et al.
Cancer Epidemiology|April 24, 2024
Side effects of drug-antibody conjugates enfortumab-vedotin and sacituzumab-govitecan in targeted therapy in cancerMoritz J Reike, Henning Bahlburg, Mirco Brehmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapyJoep J de Jong, Moritz J Reike, Yair Lotan, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2025
Functional Outcomes in Patients With Prostate Cancer Undergoing Frozen Section Guided Radical ProstatectomyMoritz J Reike, Karl H Tully, Maximilian Schulmeier, et al.
Clinical Genitourinary Cancer|October 25, 2024
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 StudyMoritz J Reike, Daniele Raggi, Chiara Mercinelli, et al.
BJU International|May 7, 2021
Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra-operative frozen sectionKarl H Tully, Max Schulmeyer, Julian Hanske, et al.
Urologia Internationalis|January 21, 2024
An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder CancerMoritz J Reike, Alina Reicherz, Karl H Tully, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Urologic Clinics of North America|November 24, 2022
Biological Stratification of Invasive and Advanced Urothelial CarcinomaMoritz J Reike, Alberto Contreras-Sanz, Peter C Black
Urologic Oncology|December 31, 2023
A systematic review of nanocarriers for treatment of urologic cancersAmy J Y Wang, Cathy Yan, Moritz J Reike, et al.
Urologia Internationalis|December 30, 2025
Who needs a postoperative radiological anastomotic control following radical prostatectomy before catheter removal on postoperative day 3? - Analysis of risk factors predicting anastomotic leakageAnalena Handke, Martina Dellino, Joachim Noldus, et al.
Urologia Internationalis|December 16, 2024
Discrimination of T-Stage Using Tumor Weight and Size: A Potential Approach to Guide Perioperative Decision-Making in Patients with Bladder CancerKarl Tully, Henning Bahlburg, Moritz J Reike, et al.
Cancer Epidemiology|April 24, 2024
Side effects of drug-antibody conjugates enfortumab-vedotin and sacituzumab-govitecan in targeted therapy in cancerMoritz J Reike, Henning Bahlburg, Mirco Brehmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2025
Molecular characterization of residual muscle-invasive bladder cancer identifies a scar-like transcriptomicprofile with favorable prognosis after neoadjuvant therapyJoep J de Jong, Moritz J Reike, Yair Lotan, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2025
Functional Outcomes in Patients With Prostate Cancer Undergoing Frozen Section Guided Radical ProstatectomyMoritz J Reike, Karl H Tully, Maximilian Schulmeier, et al.
Clinical Genitourinary Cancer|October 25, 2024
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 StudyMoritz J Reike, Daniele Raggi, Chiara Mercinelli, et al.
BJU International|May 7, 2021
Identification of patients at risk for biochemical recurrence after radical prostatectomy with intra-operative frozen sectionKarl H Tully, Max Schulmeyer, Julian Hanske, et al.
Urologia Internationalis|January 21, 2024
An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder CancerMoritz J Reike, Alina Reicherz, Karl H Tully, et al.
Pageof 2